Home › Endometriumkanker › Ohio › Cincinnati
Endometriumkanker klinische studies in Cincinnati, OH
13 studies voor Endometriumkanker zoeken deelnemers op locaties in en rond Cincinnati (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- Good Samaritan Hospital - Cincinnati, Cincinnati
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RekruterenFase 2
- Research Site, Cincinnati
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RekruterenFase 3
- University of Cincinnati Medical Center, Cincinnati
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekruterenFase 3
- Research Site, Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekruterenFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruterenFase 1
- St. Elizabeth Healthcare, Edgewood · 8 mijl verwijderd
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RekruterenFase 2
- University of Cincinnati Cancer Center, Cincinnati
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Oncology Hematology Care Primary, Cincinnati
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruterenFase 3
- Research Site, Cincinnati
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
RekruterenFase 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
RekruterenFase 2
- University of Cincinnati Medical Center, Cincinnati
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RekruterenFase 1/2
- The Christ Hospital, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Cincinnati
Endometriumkanker studies in andere steden
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Queens, NY25 studies
- Columbus, OH25 studies
- Chicago, IL25 studies
Andere studies in Cincinnati
- Niet-kleincellige longkanker35 studies
- Kanker (alle vormen)27 studies
- Borstkanker25 studies
- Hartfalen24 studies
- Colorectale kanker21 studies
- Acute myeloïde leukemie20 studies
- Metastatische kanker20 studies
- Eierstokkanker19 studies
- Longkanker19 studies
- Obesitas19 studies
- Prostaatkanker18 studies
- Multipel myeloom17 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.